• LIVING WITH CRC

    5-FU and capecitabine show distinct side-effect profiles in observational study

    In 91 patients receiving active chemotherapy, loss of appetite and nausea were more frequent with 5-FU, while diarrhea was less common with capecitabine; the observational design does not permit causal conclusions. (Diagnostics)